Cargando…
Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Effective treatment of HCC patients is hampered by the lack of sensitive and specific diagnostic markers of HCC. Alpha-fetoprotein (AFP), the currently used HCC marker, misses 30%–50% of HCC patients, who therefore...
Autores principales: | Sun, Hongbo, Chua, Mei-Sze, Yang, Dorothy, Tsalenko, Anya, Peter, Brian J., So, Samuel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688354/ https://www.ncbi.nlm.nih.gov/pubmed/19578489 |
Ejemplares similares
-
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
por: Wei, Wei, et al.
Publicado: (2009) -
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
por: Wei, Wei, et al.
Publicado: (2011) -
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling
por: Lu, Wen-Jing, et al.
Publicado: (2015) -
Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells
por: Ma, Li, et al.
Publicado: (2015) -
A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts
por: Natarajan, Arutselvan, et al.
Publicado: (2021)